Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds

…, M Miralpeix, JM Palacios, A Castro, A Martinez

文献索引：Segarra, Victor; Crespo, M. Isabel; Pujol, Ferran; Beleta, Jorge; Domenech, Teresa; Miralpeix, Montserrat; Palacios, Jose M.; Castro, Ana; Martinez, Ana Bioorganic and Medicinal Chemistry Letters, 1998 , vol. 8, # 5 p. 505 - 510

全文：HTML全文

被引用次数: 63

摘要

A 4-centre PDE 4 pharmacophore search has been carried out in several 3D-databases containing compounds belonging to different therapeutic areas. Losartan, an angiotensin-II antagonist, has been identified as a new lead compound for developping PDE 4 inhibitors. New families of compounds derived from losartan has been synthesized and their PDE inhibition has been measured.